A novel simple scoring model for predicting severity of patients with SARS‐CoV‐2 infection

Y Dong, H Zhou, M Li, Z Zhang, W Guo… - Transboundary and …, 2020 - Wiley Online Library
An outbreak of pneumonia caused by a novel coronavirus (COVID‐19) began in Wuhan,
China in December 2019 and quickly spread throughout the country and world. An efficient …

Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19

G Arora, J Joshi, RS Mandal, N Shrivastava, R Virmani… - Pathogens, 2021 - mdpi.com
As of August 6th, 2021, the World Health Organization has notified 200.8 million laboratory-
confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic …

Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV‐2

A Gour, D Manhas, S Bag, B Gorain… - Phytotherapy …, 2021 - Wiley Online Library
Emergence of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection,
COVID‐19, has become the global panic since December 2019, which urges the global …

[HTML][HTML] Novel coronavirus disease (COVID-19) pandemic: A recent mini review

MF ur Rehman, C Fariha, A Anwar, N Shahzad… - Computational and …, 2021 - Elsevier
The COVID-19, caused by a novel coronavirus, was declared as a global pandemic by WHO
more than five months ago, and we are still experiencing a state of global emergency. More …

Outbreak of COVID-19: a detailed overview and its consequences

S Shivalkar, MS Pingali, A Verma, A Singh… - … Therapeutics–Volume II …, 2022 - Springer
Introduction: After the outbreak from Wuhan City of China, COVID-19, caused by SARS-CoV-
2, has become a pandemic worldwide in a very short span of time. The high transmission …

Coronavirus disease of 2019: a mimicker of dengue infection?

J Henrina, ICS Putra, S Lawrensia… - SN Comprehensive …, 2020 - Springer
At the beginning of 2020, the national health system and medical communities are faced
with unprecedented public health challenges. A novel strain of coronavirus, later identified …

[HTML][HTML] Alternativas terapéuticas para el manejo de la COVID-19

JJ Gómez Tejeda, RA Dieguez Guach… - Revista Habanera de …, 2020 - scielo.sld.cu
Introducción: La COVID-19 es una pandemia causada por el Coronavirus 2 del Síndrome
Respiratorio Agudo Severo (SARS-CoV-2); no existe hasta el momento tratamiento …

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and …

R Hasseli, U Mueller-Ladner, T Schmeiser… - RMD open, 2020 - rmdopen.bmj.com
Objectives Patients with inflammatory rheumatic diseases (IRD) infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe …

Targeting macrophages as a therapeutic option in coronavirus disease 2019

M Gracia-Hernandez, EM Sotomayor… - Frontiers in …, 2020 - frontiersin.org
Immune cells of the monocyte/macrophage lineage are characterized by their diversity,
plasticity, and variety of functions. Among them, macrophages play a central role in antiviral …

[HTML][HTML] Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine

BM Bakadia, F He, T Souho, L Lamboni… - Biomedicine & …, 2021 - Elsevier
The ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has drawn the attention of researchers and clinicians from several disciplines …